On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Afrigen Biologics Ltd's own share of each project, not the project's full budget.
- Horizon Europe€844k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- ACTTIVACPartner
A Phase 2a Randomised Clinical Trial to Identify the Optimal Dose of the Thermostable ID93+GLA-SE Tuberculosis Vaccine for Further Clinical Evaluation and Local Manufacture in Africa
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€844ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- University of Cape TownSouth Africa · 1 shared project
- Stichting Tuberculosis Vaccine InitiativeNetherlands · 1 shared project
- The Aurum Institute NpcSouth Africa · 1 shared project
- Access to Advanced Health (UK) LTDUnited Kingdom · 1 shared project
- Bioinformatico (Pty) LtdSouth Africa · 1 shared project
- Obafemi Awolowo UniversityNigeria · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- employment
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.